Evidence map›Paper›PMID 28884008›Full record

ArticleFuture science OA2017

Efficient method to create integration-free, virus-free,

Anant Kamath, Sara Ternes, Stephen McGowan, Anthony English, Rama Mallampalli, Alan B Moy

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Future science OA, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
0.8field-weighted citation impact, top 29% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 11 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Review
  6. Review
  7. Welcome to volume 4 ofFuture science OA · 2018
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 4 institutions in 1 country.

Anant KamathCellular Engineering Technologies, Inc., 2500 Crosspark Rd, E110, Coralville, IA 52241, USA.
Sara TernesThe John Paul II Medical Research Institute, Iowa City, IA, USA.
Stephen McGowanDepartment of Internal Medicine, Roy J & Lucille A Carver College of Medicine, University of Iowa, Iowa City, IA, USA.
Anthony EnglishDepartment of Biomedical Engineering, Western New England University College of Engineering, Springfield, MA, USA.
Rama MallampalliDivision of Pulmonary, Allergy & Critical Care, University of Pittsburgh Medical Center Health System, Pittsburgh, PA, USA.
Alan B MoyCellular Engineering Technologies, Inc., 2500 Crosspark Rd, E110, Coralville, IA 52241, USA.
John Paul II Medical Research Institute · USUniversity of Iowa · USUniversity of Pittsburgh Medical Center · USWestern New England University · US

Funding

F box-Induced Acute Lung Injury and ParkinR01HL096376 · NHLBI · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI MALLAMPALLI, RAMA K · 2010 to 2025
$5.1M
Stabilizing mitochondria in sepsisR01HL098174 · NHLBI · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI MALLAMPALLI, RAMA K · 2010 to 2021
$3.6M
NHLBI NIH HHS R01 HL096376NHLBI NIH HHS R01 HL098174
6 · The paper itself

Abstract

aimNonviral induced pluripotent stem cell (IPSC) reprogramming is not efficient without the oncogenes,

methodsIPSC colony formation was compared in the presence and absence of

resultsWhile more colonies were observed in cultures transfected with the aforementioned oncogenes, the

conclusionThis approach satisfies an important regulatory pathway for developing IPSC cell therapies with lower clinical risk.

Indexed as

episomalIPS cellreprogramming

Identifiers

PMID28884008
PMCPMC5583652
OpenAlexW2613837086

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.